| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |